WO2010143767A1 - Composition for preventing and relieving hyperlipidemia comprising extracts of citrus tangerina peel, diospyrus kaki thunb., a chinese matrimony vine, and fagopyrum esculentum leaves and method of manufacturing same - Google Patents

Composition for preventing and relieving hyperlipidemia comprising extracts of citrus tangerina peel, diospyrus kaki thunb., a chinese matrimony vine, and fagopyrum esculentum leaves and method of manufacturing same Download PDF

Info

Publication number
WO2010143767A1
WO2010143767A1 PCT/KR2009/003371 KR2009003371W WO2010143767A1 WO 2010143767 A1 WO2010143767 A1 WO 2010143767A1 KR 2009003371 W KR2009003371 W KR 2009003371W WO 2010143767 A1 WO2010143767 A1 WO 2010143767A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
hyperlipidemia
preventing
peel
diospyrus
Prior art date
Application number
PCT/KR2009/003371
Other languages
French (fr)
Korean (ko)
Inventor
복성해
최명숙
박영민
Original Assignee
(주)바이오뉴트리젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)바이오뉴트리젠 filed Critical (주)바이오뉴트리젠
Publication of WO2010143767A1 publication Critical patent/WO2010143767A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/44Ebenaceae (Ebony family), e.g. persimmon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Definitions

  • the present invention relates to a composition and a method for preventing and improving hyperlipidemia containing tangerine peel, persimmon, wolfberry and buckwheat leaf extract, and more particularly in the blood due to the active ingredients contained in the tangerine peel, persimmon, wolfberry and buckwheat leaf
  • the present invention relates to a composition and a method for preventing and improving hyperlipidemia, which can reduce not only total cholesterol but also triglyceride content.
  • Hyperlipidemia is a condition in which fat, such as cholesterol, triglycerides and low density lipoprotein (LDL), is abnormally increased in the blood. Total cholesterol, triglycerides, or both are elevated.
  • LDL low density lipoprotein
  • Hyperlipidemia is not usually symptomatic in itself, but if there is a lot of fat in the blood, it can stick to the walls of blood vessels, causing arteriosclerosis, which can lead to coronary heart disease, cerebrovascular disease, and peripheral vascular obstruction.
  • the antihyperlipidemic agent has an effect of lowering cholesterol and triglyceride content, but has side effects such as hepatotoxicity, gastrointestinal disorder and carcinogenicity.
  • the present inventors continued the research based on the patented filed technology, and completed the present invention by confirming that the extracts of persimmon, wolfberry and buckwheat leaf reduced not only blood cholesterol but also triglyceride content.
  • an object of the present invention is to provide a composition and a method for producing and preventing hyperlipidemia, including a plant extract, which can reduce not only total cholesterol in the blood but also triglyceride content without side effects.
  • Preparing a mixture by mixing 90 to 110 parts by weight of persimmon, 90 to 110 parts by weight of goji berries and 30 to 40 parts by weight of buckwheat leaf, based on 100 parts by weight of tangerine;
  • composition for preventing and improving hyperlipidemia comprising a.
  • composition for preventing and improving hyperlipidemia prepared by the above method.
  • Hyperlipidemia prevention and improvement composition comprising tangerine, persimmon, goji berry and buckwheat leaf extract according to the present invention has no side effects by using only natural ingredients, it has the effect of reducing the total cholesterol content as well as blood total cholesterol. Therefore, it can be usefully used in treating hyperlipidemia patients.
  • hypolipidemia refers to a state in which fat metabolism such as triglyceride (TG) and total cholesterol (Total Cholesterol: TC) is not properly performed, and thus the amount of fat in the blood is increased.
  • TG triglyceride
  • Total Cholesterol Total Cholesterol
  • 90 to 110 parts by weight per 100 parts by weight of tangerine, 90 to 110 parts by weight of goji berry and 30 to 40 parts by weight of buckwheat leaf were added at a temperature of 100 ° C. by adding 5 to 15 times water based on the total amount of the mixture.
  • the extract can be repeatedly extracted twice by hot water extraction for 2 hours to 10 hours, filtered and concentrated under reduced pressure. Yield is 18 to 22%.
  • Extracts of the invention can be prepared in powder form by additional procedures such as freeze drying or spray drying.
  • the tangerine, persimmon, wolfberry and buckwheat leaf are preferably washed and then dried and used for preparing the extract.
  • the peel of the pollution-free tangerine grown without using pesticide it is preferable to use the peel of the pollution-free tangerine grown without using pesticide.
  • the tangerine is known to have a variety of pharmacological activity, for example, lipid metabolism-improving effect, anticancer and antiviral action associated with cardiovascular disease.
  • naringin contained in the tangerine or naringenin obtained by removing glycosides from naringin is known to lower cholesterol, anti-cancer ulcers (protection from alcohol).
  • the persimmon of this invention may use either a persimmon fruit or a persimmon leaf.
  • persimmons According to the herbaceous tree and synonym of the persimmons, it has been recorded that it helps digestion, strengthens the organs, and has pharmacological effects such as hemostasis, relieving asthma, hangover, intestinal action, tonic action, etc. It is also reported to be effective in preventing adult diseases. These effects on persimmons are evaluated by the effects of catechin, kaempherol, quercetin and tannin contained in persimmon.
  • the persimmon is preferably mixed 90 to 110 parts by weight with respect to 100 parts by weight of tangerine, and when mixed with more than 110 parts by weight, there is a problem that the synergistic increase pattern of hyperlipidemia improving efficacy achieved by each active ingredient is weakened, 90 weight There is a problem that the effective ingredient of the persimmon is insignificant if it is mixed less than a part.
  • the wolfberry of the present invention may use any of wolfberry fruit or wolfberry leaves.
  • the wolfberry (Lycium chinense) is known to have a hypoglycemic action, lowering cholesterol concentration and hepatocyte protection. These effects on the wolfberry are evaluated by the effects of betaine (betaine) contained in the wolfberry.
  • the wolfberry is preferably mixed 90 to 110 parts by weight with respect to 100 parts by weight of tangerine, there is a problem that the synergistic increase pattern of hyperlipidemia improving efficacy achieved by each active ingredient is weakened when mixed with more than 110 parts by weight, 90 If the mixture is less than the weight part, there is a problem that the active ingredient of the wolfberry is insignificant.
  • Buckwheat leaf of the present invention is known to have a cholesterol lowering action, blood sugar lowering action. These effects on the buckwheat leaf are evaluated by the rutin contained in the buckwheat leaf.
  • the buckwheat leaf is preferably mixed 30 to 40 parts by weight with respect to 100 parts by weight of tangerine, there is a problem that the synergistic increase pattern of hyperlipidemia improving efficacy achieved by each active ingredient is weakened when mixed with more than 40 parts by weight, If the mixture is less than 30 parts by weight, the active ingredient of the buckwheat leaf has a slight problem.
  • compositions containing the extract of tangerine, persimmon, goji berry and buckwheat leaf according to the present invention as an active ingredient can be administered orally or orally by dividing the amount of 3 to 10 g 1 to 3 times a day for adults. It is to be understood that the dosage for a particular patient should be determined in light of several relevant factors such as the weight, age, sex, health condition, diet, time of administration, method of administration, severity of the disease, etc. In no way is the present invention limited to a scope.
  • composition comprising the extract of tangerine, persimmon, goji berry and buckwheat leaf according to the present invention as an active ingredient can be used for the purpose of preventing and improving hyperlipidemia, and may be used as a pharmaceutical, functional food, health food or food additives.
  • the composition may be prepared as a warning agent, granules, powders, syrups, solutions, liquid extracts, emulsions, suspensions, tablets, injections, spirits, capsules or pills.
  • the hyperlipidemic effect of the extract prepared in Example 1 was confirmed in hyperlipidemic patients.
  • the present invention is not clinically tested in experimental animals, clinical trials in patients with hyperlipidemia, it is meaningful that the total cholesterol in the blood as well as the content of triglycerides can be reduced.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a method of manufacturing a composition for preventing and relieving hyperlipidemia comprising extracts of Citrus tangerina peel, Diospyrus kaki Thunb., Chinese matrimony vines, and Fagopyrum esculentum leaves, and more particularly to a method for manufacturing a composition for preventing and relieving hyperlipidemia, which can reduce the content of neutral fat as well as total blood cholesterol due to active ingredients contained in Citrus tangerina peel, Diospyrus kaki Thunb., Chinese matrimony vines, and Fagopyrum esculentum leaves. The composition for preventing and relieving hyperlipidemia of the present invention containing the extracts of Citrus tangerina peel, Diospyrus kaki Thunb., Chinese matrimony vines, and Fagopyrum esculentum leaves do not cause side effects due to the use of only natural materials and reduces the content of neutral fat as well as total blood cholesterol. Therefore, the composition can be used in treating hyperlipidemic patients.

Description

귤피, 감, 구기자 및 메밀잎 추출물을 포함하는 고지혈증 예방 및 개선용 조성물 및 그 제조방법Hyperlipidemia prevention and improvement composition comprising tangerine peel, persimmon, wolfberry and buckwheat leaf extract and method for producing same
본 발명은 귤피, 감, 구기자 및 메밀잎 추출물을 함유하는 고지혈증 예방 및 개선용 조성물 및 제조방법에 관한 것으로서, 보다 상세하게는 귤피, 감, 구기자 및 메밀잎에 포함되어 있는 유효성분으로 인해 혈액 내 총 콜레스테롤뿐만 아니라 중성지방 함량을 감소시킬 수 있는 고지혈증 예방 및 개선용 조성물 및 제조방법에 관한 것이다.The present invention relates to a composition and a method for preventing and improving hyperlipidemia containing tangerine peel, persimmon, wolfberry and buckwheat leaf extract, and more particularly in the blood due to the active ingredients contained in the tangerine peel, persimmon, wolfberry and buckwheat leaf The present invention relates to a composition and a method for preventing and improving hyperlipidemia, which can reduce not only total cholesterol but also triglyceride content.
고지혈증(Hyperlipidemia)이란 혈액 내에 콜레스테롤, 중성지방, 저밀도지단백질(LDL) 등의 지방질이 비정상적으로 증가된 상태를 말하며, 총 콜레스테롤이나 중성지방 혹은 두 가지가 모두 상승되어 있는 상태를 말한다.Hyperlipidemia is a condition in which fat, such as cholesterol, triglycerides and low density lipoprotein (LDL), is abnormally increased in the blood. Total cholesterol, triglycerides, or both are elevated.
고지혈증은 대개 그 자체가 증상을 나타내는 것은 아니지만, 혈액 내에 지방 성분이 많으면 혈관 벽에 달라붙어 동맥경화를 일으키고, 이로 인해 관상동맥 심장질환이나 뇌혈관 질환, 말초혈관 폐쇄 등을 발생시킬 수 있다. Hyperlipidemia is not usually symptomatic in itself, but if there is a lot of fat in the blood, it can stick to the walls of blood vessels, causing arteriosclerosis, which can lead to coronary heart disease, cerebrovascular disease, and peripheral vascular obstruction.
고지혈증의 치료방법으로는 콜레스테롤이나 포화지방산이 많이 들어 있는 식품의 섭취를 억제하고 열량섭취를 줄이는 식이요법, 운동요법 및 약물요법 등이 권장되고 있다.As a treatment for hyperlipidemia, it is recommended to reduce the intake of foods containing a lot of cholesterol or saturated fatty acids and to reduce the intake of calories, exercise and drug therapy.
그러나, 식이요법이나 운동요법은 엄격한 관리 및 실시가 곤란하며, 그 효과에 한계가 있는 경우가 많다. 또한 고지혈증 치료제는 콜레스테롤 및 중성지방 함량을 낮추는 효과가 있지만, 간독성, 위장장애 및 발암성 등의 부작용이 있다.However, diet and exercise therapy are difficult to carry out strict management and implementation, and the effect is often limited. In addition, the antihyperlipidemic agent has an effect of lowering cholesterol and triglyceride content, but has side effects such as hepatotoxicity, gastrointestinal disorder and carcinogenicity.
이에 따라, 인체에 안전하며 부작용이 없으면서도 고지혈증을 예방 또는 개선할 수 있는 기능성 식품의 개발이 활발히 이루어지고 있다.Accordingly, the development of functional foods that are safe for the human body and can prevent or improve hyperlipidemia without side effects have been actively made.
지방의 과잉 섭취는 비만의 원인이 될 뿐만 아니라, 고지혈증이나 그에 수반되는 동맥 경화증, 지방간 등의 발병 리스크를 높이는 것으로 지적되고 있다.It is pointed out that excessive consumption of fat not only causes obesity, but also increases the risk of developing hyperlipidemia, accompanying arteriosclerosis, fatty liver, and the like.
지방, 특히 콜레스테롤의 과잉 섭취에 의한 순환기계 질환 발병 리스크의 증대에 대해서는 일반적으로 알려져 있어, 혈청 콜레스테롤 수치를 관리할 필요성이 언급되고 있었다. 그러나, 그 후 혈중 중성지방 수치와, 관동맥 질환에 의한 사망자 수 사이에 상관 관계가 인정되었고, 그 상관은 콜레스테롤보다도 강하다는 것이 보고되었다. 또한, 이를 지지하는 보고가 계속되었고, 그 결과 중성지방 수치가 동맥 경화의 위험 인자임이 증명되었다.Increased risk of developing circulatory disease due to excessive intake of fat, particularly cholesterol, is generally known, and the need for managing serum cholesterol levels has been mentioned. However, a correlation between blood triglyceride levels and the number of deaths from coronary artery disease has since been recognized and reported to be stronger than cholesterol. In addition, reports continue to support this, demonstrating that triglyceride levels are a risk factor for atherosclerosis.
본 발명자는 헤스페리딘, 헤스페레틴, 나린진 및 나린제닌이 풍부하게 함유된 감귤류 과피 추출물이 혈중 콜레스테롤을 감소시키는 것을 확인하여 특허출원한 바 있다. (대한민국 특허공개번호 2001-0015512) The present inventors have filed a patent application confirming that citrus peel extracts rich in hesperidin, hesperetin, naringin and naringenin reduce blood cholesterol. (Korean Patent Publication No. 2001-0015512)
본 발명자는 상기 출원된 특허기술을 바탕으로 연구를 계속하였으며, 귤피에 감, 구기자 및 메밀잎을 혼합한 추출물이 혈중 콜레스테롤 뿐만 아니라 중성지방 함량을 감소시키는 것을 확인함으로 본 발명을 완성하게 되었다.The present inventors continued the research based on the patented filed technology, and completed the present invention by confirming that the extracts of persimmon, wolfberry and buckwheat leaf reduced not only blood cholesterol but also triglyceride content.
따라서 본 발명의 목적은 부작용이 없으면서, 혈중 총 콜레스테롤 뿐만 아니라 중성지방 함량을 감소시킬 수 있는, 식물 추출물을 포함하는 고지혈증 예방 및 개선용 조성물 및 제조방법을 제공하는 것이다.Accordingly, an object of the present invention is to provide a composition and a method for producing and preventing hyperlipidemia, including a plant extract, which can reduce not only total cholesterol in the blood but also triglyceride content without side effects.
본 발명의 상기 목적은,The above object of the present invention,
귤피 100 중량부에 대하여 감 90 내지 110 중량부, 구기자 90 내지 110 중량부 및 메밀잎 30 내지 40 중량부를 혼합하여 혼합물을 제조하는 단계;Preparing a mixture by mixing 90 to 110 parts by weight of persimmon, 90 to 110 parts by weight of goji berries and 30 to 40 parts by weight of buckwheat leaf, based on 100 parts by weight of tangerine;
상기 혼합물에 혼합물의 총량을 기준으로 5배 내지 15배의 물을 첨가하여 100℃에서 2시간 내지 10시간 동안 열수추출 방법에 의해 2회 반복 추출하여 추출액을 얻는 단계;Adding 5 times to 15 times water based on the total amount of the mixture to the mixture to extract the extract twice by 100 times at 100 ° C. for 2 to 10 hours;
상기 추출액을 여과 및 감압 농축하는 단계; 및Filtration and concentration of the extract under reduced pressure; And
상기 감압 농축된 추출액을 동결 건조 또는 분무 건조하여 추출물을 제조하는 단계;Preparing an extract by freeze drying or spray drying the extract concentrated under reduced pressure;
를 포함하는 것을 특징으로 하는 고지혈증 예방 및 개선용 조성물 제조방법에 의해서 달성된다.It is achieved by a method for producing a composition for preventing and improving hyperlipidemia comprising a.
또한, 본 발명의 상기 목적은,In addition, the above object of the present invention,
상기 제조방법으로 제조되는 고지혈증 예방 및 개선용 조성물에 의해서 달성된다.It is achieved by a composition for preventing and improving hyperlipidemia prepared by the above method.
본 발명에 따른 귤피, 감, 구기자 및 메밀잎 추출물을 포함하는 고지혈증 예방 및 개선용 조성물은 천연재료만을 사용함으로 인해 부작용이 없으며, 혈중 총 콜레스테롤 뿐만 아니라 중성지방 함량을 감소시킬 수 있는 효과가 있다. 따라서 고지혈증 환자를 치료하는데 있어서 유용하게 사용될 수 있다.Hyperlipidemia prevention and improvement composition comprising tangerine, persimmon, goji berry and buckwheat leaf extract according to the present invention has no side effects by using only natural ingredients, it has the effect of reducing the total cholesterol content as well as blood total cholesterol. Therefore, it can be usefully used in treating hyperlipidemia patients.
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 명세서에서, 용어 "고지혈증"은 중성지방(Triglyceride: TG)과 총 콜레스테롤(Total Cholesterol: TC) 등의 지방대사가 제대로 이루어지지 않아 혈액 중에 지방량이 많아진 상태를 의미한다.In the present specification, the term "hyperlipidemia" refers to a state in which fat metabolism such as triglyceride (TG) and total cholesterol (Total Cholesterol: TC) is not properly performed, and thus the amount of fat in the blood is increased.
본 발명에 따른 고지혈증 예방 및 개선용 추출물은,Hyperlipidemia prevention and improvement extract according to the present invention,
귤피 100 중량부에 대하여 감 90 내지 110 중량부, 구기자 90 내지 110 중량부 및 메밀잎 30 내지 40 중량부를 혼합한 혼합물에 혼합물의 총량을 기준으로 5배 내지 15배의 물을 첨가하여 100℃에서 2시간 내지 10시간 열수추출 방법에 의해 2회 반복 추출하고, 여과 및 감압 농축하여 얻을 수 있다. 수득율은 18 내지 22%이다.90 to 110 parts by weight per 100 parts by weight of tangerine, 90 to 110 parts by weight of goji berry and 30 to 40 parts by weight of buckwheat leaf were added at a temperature of 100 ° C. by adding 5 to 15 times water based on the total amount of the mixture. The extract can be repeatedly extracted twice by hot water extraction for 2 hours to 10 hours, filtered and concentrated under reduced pressure. Yield is 18 to 22%.
본 발명의 추출물은 동결 건조 또는 분무 건조와 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다. Extracts of the invention can be prepared in powder form by additional procedures such as freeze drying or spray drying.
상기 귤피, 감, 구기자 및 메밀잎은 세척한 후 건조한 건조 시료를 추출물 조제에 사용하는 것이 바람직하다.The tangerine, persimmon, wolfberry and buckwheat leaf are preferably washed and then dried and used for preparing the extract.
본 발명의 귤피는 농약을 사용하지 않고 재배한 무공해 귤의 껍질을 사용하는 것이 바람직하다.As for the tangerine of this invention, it is preferable to use the peel of the pollution-free tangerine grown without using pesticide.
상기 귤피는 각종 약리활성작용, 예를 들어, 심장순환기 질환과 관련된 지질대사 개선 효과, 항암 및 항바이러스 작용 등을 가진 것으로 알려져 있다. 귤피에 포함되어 있는 헤스페리딘(hesperidin) 또는 헤스페리딘에서 배당체를 제거하여 얻는 헤스페레틴은 모세혈관 강화, 투과성(Permeability)감소, 혈압 강하, 혈중 콜레스테롤 강하, 항혈소판 응집, 항염증 및 항바이러스 작용을 한다고 알려져 있다.The tangerine is known to have a variety of pharmacological activity, for example, lipid metabolism-improving effect, anticancer and antiviral action associated with cardiovascular disease. Hesperidin from hesperidin or hesperidin, which is included in the tangerine, has been shown to be effective in capillary potentiation, decreased permeability, lowered blood pressure, lowered blood cholesterol, anti-platelet aggregation, anti-inflammatory and antiviral effects. Known.
또한, 귤피에 포함되어 있는 나린진(naringin) 또는 나린진에서 배당체를 제거하여 얻는 나린제닌은 콜레스테롤 강하, 항암 항위궤양(알콜로부터 보호) 작용을 한다고 알려져 있다.In addition, naringin (naringin) contained in the tangerine or naringenin obtained by removing glycosides from naringin is known to lower cholesterol, anti-cancer ulcers (protection from alcohol).
본 발명의 감은 감 열매 또는 감잎 중 어느 것을 사용해도 무방하다. The persimmon of this invention may use either a persimmon fruit or a persimmon leaf.
상기 감은 본초강목 및 동의보감에 의하면 소화기능을 돕고 장기를 튼튼히 하며 지혈, 해소천식, 숙취, 정장작용, 강장작용 등의 약리작용이 있는 것으로 기록되어 있으며, 최근의 실험적 연구에 의하면 동맥경화, 고혈압 등의 성인병 예방에도 효과가 있는 것으로 보고되고 있다. 감에 나타나는 이러한 효과들은 감에 함유된 카테킨(catechin), 캠퍼롤(kaempherol), 케르세틴(quercetin) 및 타닌(tannin)에 의한 효과로 평가되고 있다. 상기 감은 귤피 100 중량부에 대하여 90 내지 110 중량부 혼합하는 것이 바람직하며, 110 중량부 초과 혼합하면 각각의 유효성분에 의해 달성되는 고지혈증 개선 효능의 상승적인 증가 패턴이 약화되는 문제점이 있으며, 90 중량부 미만 혼합하면 감의 유효성분이 미미한 문제가 있다.According to the herbaceous tree and synonym of the persimmons, it has been recorded that it helps digestion, strengthens the organs, and has pharmacological effects such as hemostasis, relieving asthma, hangover, intestinal action, tonic action, etc. It is also reported to be effective in preventing adult diseases. These effects on persimmons are evaluated by the effects of catechin, kaempherol, quercetin and tannin contained in persimmon. The persimmon is preferably mixed 90 to 110 parts by weight with respect to 100 parts by weight of tangerine, and when mixed with more than 110 parts by weight, there is a problem that the synergistic increase pattern of hyperlipidemia improving efficacy achieved by each active ingredient is weakened, 90 weight There is a problem that the effective ingredient of the persimmon is insignificant if it is mixed less than a part.
본 발명의 구기자는 구기자 열매 또는 구기자잎 중 어느 것을 사용해도 무방하다.The wolfberry of the present invention may use any of wolfberry fruit or wolfberry leaves.
상기 구기자(Lycium chinense)는 혈당강하작용, 콜레스테롤농도 저하작용 및 간세포 보호작용이 있다고 알려져 있다. 구기자에 나타나는 이러한 효과들은 구기자에 함유된 베타인(betaine)에 의한 효과로 평가되고 있다.The wolfberry (Lycium chinense) is known to have a hypoglycemic action, lowering cholesterol concentration and hepatocyte protection. These effects on the wolfberry are evaluated by the effects of betaine (betaine) contained in the wolfberry.
상기 구기자는 귤피 100 중량부에 대하여 90 내지 110 중량부 혼합하는 것이 바람직하며, 110 중량부 초과 혼합하면 각각의 유효성분에 의해 달성되는 고지혈증 개선 효능의 상승적인 증가 패턴이 약화되는 문제가 있으며, 90 중량부 미만 혼합하면 구기자의 유효성분이 미미한 문제가 있다.The wolfberry is preferably mixed 90 to 110 parts by weight with respect to 100 parts by weight of tangerine, there is a problem that the synergistic increase pattern of hyperlipidemia improving efficacy achieved by each active ingredient is weakened when mixed with more than 110 parts by weight, 90 If the mixture is less than the weight part, there is a problem that the active ingredient of the wolfberry is insignificant.
본 발명의 메밀잎은 콜레스테롤 저하 작용, 혈당 저하작용이 있다고 알려져 있다. 메밀잎에 나타나는 이러한 효과들은 메밀잎에 함유된 루틴(rutin)에 의한 효과로 평가되고 있다.Buckwheat leaf of the present invention is known to have a cholesterol lowering action, blood sugar lowering action. These effects on the buckwheat leaf are evaluated by the rutin contained in the buckwheat leaf.
상기 메밀잎은 귤피 100 중량부에 대하여 30 내지 40 중량부 혼합하는 것이 바람직하며, 40 중량부 초과 혼합하면 각각의 유효성분에 의해 달성되는 고지혈증 개선 효능의 상승적인 증가 패턴이 약화되는 문제가 있으며, 30 중량부 미만 혼합하면 메밀잎의 유효성분이 미미한 문제가 있다.The buckwheat leaf is preferably mixed 30 to 40 parts by weight with respect to 100 parts by weight of tangerine, there is a problem that the synergistic increase pattern of hyperlipidemia improving efficacy achieved by each active ingredient is weakened when mixed with more than 40 parts by weight, If the mixture is less than 30 parts by weight, the active ingredient of the buckwheat leaf has a slight problem.
본 발명에 따른 귤피, 감, 구기자 및 메밀잎의 추출물을 유효성분으로 하는 조성물은 성인의 경우 1일 3 ~ 10 g의 양을 1~3 회에 나누어 경구 투여 또는 비 경구 투여할 수 있다. 특정 환자에 대한 투여 용량은 환자의 체중, 연령, 성별, 건강 상태, 식이, 투여 시간, 투여 방법, 질환의 중증도 등의 여러 관련 인자에 비추어 결정되어야 하는 것으로 이해되어야 하며, 따라서, 상기 투여량은 어떠한 면으로든 본 발명이 범위를 한정하는 것은 아니다.Compositions containing the extract of tangerine, persimmon, goji berry and buckwheat leaf according to the present invention as an active ingredient can be administered orally or orally by dividing the amount of 3 to 10 g 1 to 3 times a day for adults. It is to be understood that the dosage for a particular patient should be determined in light of several relevant factors such as the weight, age, sex, health condition, diet, time of administration, method of administration, severity of the disease, etc. In no way is the present invention limited to a scope.
또한, 본 발명에 따른 귤피, 감, 구기자 및 메밀잎의 추출물을 유효성분으로 하는 조성물은 고지혈증을 예방 및 개선하기 위한 용도로 사용될 수 있으며, 약제, 기능성 식품, 건강식품 또는 식품 첨가제로 사용될 수 있다. 상기 조성물은 경고제, 과립제, 산제, 시럽제, 액제, 유동엑스제, 에멀션제, 현탁제, 정제, 주사제, 주정제, 캡슐제 또는 환제로 제조할 수 있다.In addition, the composition comprising the extract of tangerine, persimmon, goji berry and buckwheat leaf according to the present invention as an active ingredient can be used for the purpose of preventing and improving hyperlipidemia, and may be used as a pharmaceutical, functional food, health food or food additives. . The composition may be prepared as a warning agent, granules, powders, syrups, solutions, liquid extracts, emulsions, suspensions, tablets, injections, spirits, capsules or pills.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명한다. 단, 이들 실시예는 본 발명의 예시일 뿐, 본 발명의 범위가 이들만으로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. However, these Examples are only illustrative of the present invention, and the scope of the present invention is not limited to these.
[실시예 1]Example 1
귤피 1㎏, 감 1㎏, 구기자 1㎏ 및 메밀잎 350 g 을 세척하고 건조한 후 물 30㎏을 가하여 100℃에서 5 시간씩 2회 반복 추출한 후 여과하여 찌꺼기를 제거하였다. 회수한 추출액을 온도 25℃ 및 압력 740mmHg의 농축탱크에서 5시간 동안 감압 농축한 후, 농축액을 -40℃의 온도로 유지되는 동결건조기에서 48시간 동안 동결건조하여 목적하는 추출물 시료를 제조하였다.1 kg of tangerine, 1 kg of persimmon, 1 kg of wolfberry, and 350 g of buckwheat leaf were washed, dried, 30 kg of water was added thereto, extracted twice at 100 ° C. for 5 hours, and then filtered to remove debris. The collected extract was concentrated under reduced pressure for 5 hours in a concentration tank at a temperature of 25 ° C. and a pressure of 740 mm Hg, and the concentrate was lyophilized for 48 hours in a freeze dryer maintained at a temperature of −40 ° C. to prepare a desired extract sample.
[실험예 1]Experimental Example 1
상기 실시예 1에서 제조한 추출물의 고지혈증 개선 효과를 고지혈증 환자를 대상으로 확인하였다.The hyperlipidemic effect of the extract prepared in Example 1 was confirmed in hyperlipidemic patients.
고지혈증 환자들을 선정하여 상기 실시예 1의 추출물을 공복시 하루 2회, 1회당 4.5g 복용토록 하였으며, 복용전 및 복용후의 총 콜레스테롤 및 중성지방을 측정하였고, 그 결과는 하기 표 1에 나타내었다.Patients with hyperlipidemia were selected to take 4.5 g of the extract of Example 1 twice daily, on an empty stomach, and measured total cholesterol and triglycerides before and after taking, and the results are shown in Table 1 below.
표 1
번호 성별 나이 투약일수 (복용개시일-복용마감일) 총 콜레스테롤(TC)변화 (㎎/㎗) / 저하율 중성지방(TG) 변화(㎎/㎗) / 저하율
1 28 6일 (2008.12.01.-12.06.) 294 → 228 / 22% 346 → 269 / 22%
2 39 26일 (2008.11.14.-12.09.) 229 → 168 / 27% 217 → 190 / 12%
3 44 15일 (2008.12.02.-12.16.) 251 → 211 / 16% 348 → 153 / 56%
4 56 6일 (2008.12.15.-12.20.) 131 → 124 / 5% 404 → 114 / 72%
5 58 20일 (2008.12.01.-12.20.) 198 → 122 / 38% 347 → 149 / 57%
6 68 23일 (2008.12.01.-12.23.) 195 → 162 / 17% 179 → 162 / 9%
7 53 7일 (2008.12.12.-12.18.) 178 → 142 / 20% 528 → 168 / 68%
8 57 8일 (2008.12.17.-12.24.) 274 → 273 / 0% 250 → 158 / 37%
평균 수치 / 평균 저하율 219 → 179 / 18% 327 → 170 / 48%
Table 1
number gender age Medication days (dose start-dose date) Total cholesterol (TC) change (mg / dl) / decrease rate Triglyceride (TG) change / mg rate
One male 28 6th (2008.12.01.-12.06.) 294 → 228/22% 346 → 269/22%
2 male 39 26th (2008.11.14.-12.09.) 229 → 168/27% 217 → 190/12%
3 male 44 15th (2008.12.02.-12.16.) 251 → 211/16% 348 → 153/56%
4 male 56 6th (2008.12.15.-12.20.) 131 → 124/5% 404 → 114/72%
5 male 58 20th (2008.12.01.-12.20.) 198 → 122/38% 347 → 149/57%
6 male 68 23rd (2008.12.01.-12.23.) 195 → 162/17% 179 → 162/9%
7 female 53 7th (2008.12.12.-12.18.) 178 → 142/20% 528 → 168/68%
8 female 57 8th (2008.12.17.-12.24.) 274 → 273/0% 250 → 158/37%
Average value / average rate of decline 219 → 179/18% 327 → 170/48%
상기 표 1에서 알 수 있는 바와 같이, 8 명의 성인 남여 고지혈증 환자에게 본 발명의 추출물을 하루 2회, 6일 내지 26일 동안 복용토록 한 결과, 총 콜레스테롤은 한 명을 제외하고 7명에게서 저하효과가 있었으며, 중성지방은 8명 모두에게서 저하효과가 있었다. 특별히 본 발명의 추출물은 중성지방의 함량을 낮추는데 큰 효과가 있는 것을 알 수 있다.As can be seen in Table 1, as a result of taking the extract of the present invention twice daily, 6 days to 26 days to eight adult male and female hyperlipidemia patients, total cholesterol was lowered in seven except one Triglycerides had a lowering effect in all eight patients. In particular, it can be seen that the extract of the present invention has a great effect in lowering the content of triglycerides.
특별히 본 발명은 실험동물을 대상으로 임상실험한 것이 아니고, 고지혈증 환자를 대상으로 임상실험한 결과, 혈액 내의 총 콜레스테롤뿐만 아니라 중성지방의 함량을 감소시킬 수 있다는 것을 입증한 것에 의의가 있다.In particular, the present invention is not clinically tested in experimental animals, clinical trials in patients with hyperlipidemia, it is meaningful that the total cholesterol in the blood as well as the content of triglycerides can be reduced.

Claims (2)

  1. 귤피 100 중량부에 대하여 감 90 내지 110 중량부, 구기자 90 내지 110 중량부 및 메밀잎 30 내지 40 중량부를 혼합하여 혼합물을 제조하는 단계;Preparing a mixture by mixing 90 to 110 parts by weight of persimmon, 90 to 110 parts by weight of goji berries and 30 to 40 parts by weight of buckwheat leaf, based on 100 parts by weight of tangerine;
    상기 혼합물에 혼합물의 총량을 기준으로 5배 내지 15배의 물을 첨가하여 100℃에서 2시간 내지 10시간 동안 열수추출 방법에 의해 2회 반복 추출하여 추출액을 얻는 단계;Adding 5 times to 15 times water based on the total amount of the mixture to the mixture to extract the extract twice by 100 times at 100 ° C. for 2 to 10 hours;
    상기 추출액을 여과 및 감압 농축하는 단계; 및Filtration and concentration of the extract under reduced pressure; And
    상기 감압 농축된 추출액을 동결 건조 또는 분무 건조하여 추출물을 제조하는 단계;Preparing an extract by freeze drying or spray drying the extract concentrated under reduced pressure;
    를 포함하는 것을 특징으로 하는 고지혈증 예방 및 개선용 조성물 제조방법.Method for producing a composition for preventing and improving hyperlipidemia comprising a.
  2. 제 1항에 있어서,The method of claim 1,
    상기 제조방법으로 제조되는 고지혈증 예방 및 개선용 조성물.Hyperlipidemia prevention and improvement composition prepared by the above method.
PCT/KR2009/003371 2009-06-11 2009-06-23 Composition for preventing and relieving hyperlipidemia comprising extracts of citrus tangerina peel, diospyrus kaki thunb., a chinese matrimony vine, and fagopyrum esculentum leaves and method of manufacturing same WO2010143767A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0051860 2009-06-11
KR1020090051860A KR20100133133A (en) 2009-06-11 2009-06-11 A composition containing the extract of citrus peel, persimmon, lycium chinense and buckwheat leaf for preventing or improving hyperlipidemia and manufacturing method thereof

Publications (1)

Publication Number Publication Date
WO2010143767A1 true WO2010143767A1 (en) 2010-12-16

Family

ID=43309011

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/003371 WO2010143767A1 (en) 2009-06-11 2009-06-23 Composition for preventing and relieving hyperlipidemia comprising extracts of citrus tangerina peel, diospyrus kaki thunb., a chinese matrimony vine, and fagopyrum esculentum leaves and method of manufacturing same

Country Status (2)

Country Link
KR (1) KR20100133133A (en)
WO (1) WO2010143767A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000019717A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising rutin and quercetin for preventing and treating hyperlipidemia, arteriosclerosis and liver disease
KR100254908B1 (en) * 1997-10-28 2000-05-01 복성해 3-hydroxy-3-methylglutaryl coa reductase inhibitory composition comprising vitamin c and citrus peel extract
KR100488409B1 (en) * 2002-10-23 2005-05-10 (주)바이오뉴트리젠 A coffee composition comprising polyphenols, bioflavonoids or extracts of plants comprising polyphenols or bioflavonoids for improving the metabolism of the lipid and suppressing the fatness
JP2008063332A (en) * 2006-08-11 2008-03-21 Gifu Prefecture Immature persimmon fruit powder composition and method for producing the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100254908B1 (en) * 1997-10-28 2000-05-01 복성해 3-hydroxy-3-methylglutaryl coa reductase inhibitory composition comprising vitamin c and citrus peel extract
KR20000019717A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising rutin and quercetin for preventing and treating hyperlipidemia, arteriosclerosis and liver disease
KR100488409B1 (en) * 2002-10-23 2005-05-10 (주)바이오뉴트리젠 A coffee composition comprising polyphenols, bioflavonoids or extracts of plants comprising polyphenols or bioflavonoids for improving the metabolism of the lipid and suppressing the fatness
JP2008063332A (en) * 2006-08-11 2008-03-21 Gifu Prefecture Immature persimmon fruit powder composition and method for producing the same

Also Published As

Publication number Publication date
KR20100133133A (en) 2010-12-21

Similar Documents

Publication Publication Date Title
CN106265754A (en) A kind of method that a chain of extraction obtains two kinds of effective ingredient from periplaneta americana
CN106214989A (en) A kind of defying age, the deer's blood health-care medicated wine improving memory and preparation method thereof
CN108887444A (en) A kind of health protection tea of anti-trioxypurine and preparation method thereof
US8945633B2 (en) Pharmaceutical composition for preventing and treating inflammatory diseases containing an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, and method for producing the fraction
KR101835416B1 (en) Composition for preventing stroke using the natural
CN107648297A (en) A kind of fulvoushair honeysuckle flower extract, the preparation containing the extract and the application in field of medicaments
JP4516958B2 (en) Anti-diabetic composition
KR100949482B1 (en) Phamaceutical composition of diabetes mellitus or hypertension using extract of taxus cuspidata and mulberry tree, and mamufacturing method thereof
CN104524214B (en) Treat the Chinese medicine composition and its Chinese medicine preparation, preparation method and application of digestive tract ulcer
CN1381236A (en) Medicinal composition containing baicalin and caffoeoylchinic acid
KR100733984B1 (en) A pharmaceutical composition having effects of cure and prevention of obesity and hyperlipidemia by containing konjac and extract of medicinal herbs
US20090317495A1 (en) Composition comprising trachelospermi caulis and pyrola japonica extracts for the treatment and prevention of inflammatory diseases
CN104524215B (en) Treat capsule of stomach trouble and preparation method thereof
CN104585634A (en) Rice cake for reducing blood pressure and blood lipid and preparation method thereof
CN105963330B (en) Miracle fruit preparation and its application
KR100964603B1 (en) Phamaceutical composition of diabetes mellitus using extract of taxus cuspidata and mulberry tree, and mamufacturing method thereof
WO2010143767A1 (en) Composition for preventing and relieving hyperlipidemia comprising extracts of citrus tangerina peel, diospyrus kaki thunb., a chinese matrimony vine, and fagopyrum esculentum leaves and method of manufacturing same
CN106729518A (en) A kind of tea beverage of hypotensive and preparation method and application
CN106389594A (en) Traditional Chinese medicine composition for curing nyctalopia and preparation method thereof
CN106166165A (en) A kind of American cockroach medicament composition being effectively improved various clinical treating correlative diseases effect and preparation method thereof
CN112843172A (en) Chinese and western medicinal composition for improving human body function and discharging harmful toxin, and its preparation method
CN106668040A (en) Medicinal composition for preventing and treating neonatal jaundice and preparation method and application thereof
CN103705696A (en) Method for preparing powder injection for treating diabetes by using aloes and Chinese yam
CN107811907A (en) A kind of body lotion for promoting subcutaneous fat to decompose
RU2442595C2 (en) Herbal complex for treatment of oncological diseases and method for treatment of digestive tract diseases using the said complex

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09845861

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09845861

Country of ref document: EP

Kind code of ref document: A1